scholarly journals A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses

2018 ◽  
Vol 24 (10) ◽  
pp. 2285-2293 ◽  
Author(s):  
Daniela Matei ◽  
Sharad Ghamande ◽  
Lynda Roman ◽  
Angeles Alvarez Secord ◽  
John Nemunaitis ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Clinical Trial ◽  
Phase I ◽  
Clinical Pharmacokinetic ◽  
Recurrent Ovarian Cancer ◽  
Phase I Clinical Trial ◽  
Platinum Resistant

Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer

2012 ◽  
Vol 23 (3) ◽  
pp. 321-325 ◽  
Author(s):  
Jong Ha Hwang ◽  
Heon Jong Yoo ◽  
Myong Cheol Lim ◽  
Sang-Soo Seo ◽  
Sang-Yoon Park ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Oral Etoposide ◽  
Platinum Resistant

scholarly journals A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer

2013 ◽  
Vol 130 (3) ◽  
pp. 518-524 ◽  
Author(s):  
Kenneth H. Kim ◽  
Igor P. Dmitriev ◽  
Souheil Saddekni ◽  
Elena A. Kashentseva ◽  
Raymond D. Harris ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Clinical Trial ◽  
Phase I ◽  
Recurrent Ovarian Cancer ◽  
Phase I Clinical Trial ◽  
Conditionally Replicative Adenovirus

scholarly journals Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer

Gene Therapy ◽  
2009 ◽  
Vol 17 (3) ◽  
pp. 360-369 ◽  
Author(s):  
K Anwer ◽  
M N Barnes ◽  
J Fewell ◽  
D H Lewis ◽  
R D Alvarez
Keyword(s):  
Ovarian Cancer ◽  
Clinical Trial ◽  
Phase I ◽  
Recurrent Ovarian Cancer ◽  
Phase I Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document